These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 8674056)
21. Coexpression of a multidrug resistance gene (MDR1) and herpes simplex virus thymidine kinase gene in a bicistronic retroviral vector Ha-MDR-IRES-TK allows selective killing of MDR1-transduced human tumors transplanted in nude mice. Sugimoto Y; Sato S; Tsukahara S; Suzuki M; Okochi E; Gottesman MM; Pastan I; Tsuruo T Cancer Gene Ther; 1997; 4(1):51-8. PubMed ID: 9012451 [TBL] [Abstract][Full Text] [Related]
22. P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias. Damiani D; Michieli M; Ermacora A; Candoni A; Raspadori D; Geromin A; Stocchi R; Grimaz S; Masolini P; Michelutti A; Scheper RJ; Baccarani M Haematologica; 1998 Apr; 83(4):290-7. PubMed ID: 9592977 [TBL] [Abstract][Full Text] [Related]
23. P-glycoprotein: clinical significance and methods of analysis. van der Heyden S; Gheuens E; DeBruijn E; Van Oosterom A; Maes R Crit Rev Clin Lab Sci; 1995; 32(3):221-64. PubMed ID: 7495497 [TBL] [Abstract][Full Text] [Related]
24. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer. Campling BG; Young LC; Baer KA; Lam YM; Deeley RG; Cole SP; Gerlach JH Clin Cancer Res; 1997 Jan; 3(1):115-22. PubMed ID: 9815546 [TBL] [Abstract][Full Text] [Related]
25. Strategies to circumvent multidrug resistance due to P-glycoprotein or to altered DNA topoisomerase II. Beck WT Bull Cancer; 1990; 77(11):1131-41. PubMed ID: 1980425 [TBL] [Abstract][Full Text] [Related]
26. Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells. Kang DI; Kang HK; Gwak HS; Han HK; Lim SJ Drug Deliv; 2009 Jul; 16(5):261-7. PubMed ID: 19538007 [TBL] [Abstract][Full Text] [Related]
27. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer. Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665 [TBL] [Abstract][Full Text] [Related]
28. Tissue distribution of the human MDR3 P-glycoprotein. Smit JJ; Schinkel AH; Mol CA; Majoor D; Mooi WJ; Jongsma AP; Lincke CR; Borst P Lab Invest; 1994 Nov; 71(5):638-49. PubMed ID: 7734012 [TBL] [Abstract][Full Text] [Related]
30. Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies. Grogan T; Dalton W; Rybski J; Spier C; Meltzer P; Richter L; Gleason M; Pindur J; Cline A; Scheper R Lab Invest; 1990 Dec; 63(6):815-24. PubMed ID: 1979362 [TBL] [Abstract][Full Text] [Related]
31. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. Schuetz EG; Furuya KN; Schuetz JD J Pharmacol Exp Ther; 1995 Nov; 275(2):1011-8. PubMed ID: 7473127 [TBL] [Abstract][Full Text] [Related]
32. Expression of mdr1/P-glycoprotein and p110 in neuroblastoma. Ramani P; Dewchand H J Pathol; 1995 Jan; 175(1):13-22. PubMed ID: 7891222 [TBL] [Abstract][Full Text] [Related]
33. P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance. Lee JJ; Hughes CS; Fine RL; Page RL Cancer; 1996 May; 77(9):1892-8. PubMed ID: 8646690 [TBL] [Abstract][Full Text] [Related]
34. Detection of the MDR1 P-glycoprotein expression and function. Mechetner E Methods Mol Biol; 2007; 378():175-93. PubMed ID: 18605086 [TBL] [Abstract][Full Text] [Related]
35. Multidrug resistance. Clinical opportunities in diagnosis and circumvention. Chan HS; DeBoer G; Thorner PS; Haddad G; Gallie BL; Ling V Hematol Oncol Clin North Am; 1994 Apr; 8(2):383-410. PubMed ID: 7913705 [TBL] [Abstract][Full Text] [Related]
36. P-glycoprotein stability is affected by serum deprivation and high cell density in multidrug-resistant cells. Muller C; Laurent G; Ling V J Cell Physiol; 1995 Jun; 163(3):538-44. PubMed ID: 7775597 [TBL] [Abstract][Full Text] [Related]
37. Expression of P-glycoprotein in normal muscle cells and myogenic tumors. Garberoglio C; Dudas M; Casper ES; Bertino J; Cordon-Cardo C Arch Pathol Lab Med; 1992 Oct; 116(10):1055-61. PubMed ID: 1384456 [TBL] [Abstract][Full Text] [Related]
38. MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors. Tóth K; Vaughan MM; Peress NS; Slocum HK; Rustum YM Am J Pathol; 1996 Sep; 149(3):853-8. PubMed ID: 8780389 [TBL] [Abstract][Full Text] [Related]
39. New immunohistochemical "sandwich" staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues. Tóth K; Vaughan MM; Slocum HK; Arredondo MA; Takita H; Baker RM; Rustum YM Am J Pathol; 1994 Feb; 144(2):227-36. PubMed ID: 7508682 [TBL] [Abstract][Full Text] [Related]
40. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. Cordon-Cardo C; O'Brien JP; Boccia J; Casals D; Bertino JR; Melamed MR J Histochem Cytochem; 1990 Sep; 38(9):1277-87. PubMed ID: 1974900 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]